Dana Blankenhorn

Dana Blankenhorn

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

Upstart Stock Is a Buy Now and a Buy Later Investment

At one point in October investors were paying over 30 times revenue to own Upstart, which replaces bankers with artificial intelligence software. That was too high.

Desktop Metal: For Patient Investors Only

Desktop Metal capitalized on the SPAC boom but profits are a ways off, meaning those who buy DM stock should be prepared to hold it.

Lucid Motors Still Faces Looming Market Saturation

The luxury end of the electric vehicle market may be saturated by 2025. What will Lucid and LCID stock owners do then?

AT&T Stock Is Still Recovering From the 5G Airplane Kerfuffle

AT&T stock investors need to focus on the size of its dividend in the new 5G and metaverse world that is finally coming into view.

Alphabet Stock May Look Pricey, But Only By Former Standards

Alphabet's capital spending is rising by 24% per year but Google Cloud's revenue is rising by 44%, and it's not even gaining market share.

The Two Faces of Clover Health

CTO Andrew Toy has a great tool in the Clover Assistant, which can cut the costs of treating chronic conditions among aging patients. But will he get a chance to deploy it?

If Omicron Is the End, Then Its Smooth Sailing for RCL Stock Ahead

Royal Caribbean stock has outperformed other cruise lines during the pandemic, and has been rising despite warnings from the Centers for Disease Control against cruising.

Progenity Stock’s Hype Cycle Is Over, It Needs Results

Progenity spent 2021 reinventing itself, dumping its testing laboratory, hiring a new CEO, and refocusing on its patent portfolio. PROG stock hopes its patent portfolio can result in new tests and treatments for disease, but mining it will take time and money.

Valuation Matters in the Short Term for Cloudflare Stock

Cloudflare (NYSE:NET) proves there’s a price that’s too high, even for a good company in a hot niche. I will admit that I was caught…

Virgin Galactic Stock Is Lost in Space and Going Nowhere Soon

Virgin Galactic had a noble idea to take tourists into space, but it hasn't been able to scale that into a business. Avoid SPCE stock.